Activities per year
Activities
- 36 results
Search results
-
Zukunftskonferenz 2011
Stefan Liebminger (Speaker)
4 Oct 2011Activity: Talk or presentation › Invited talk › Science to science
-
Wearable diagnostics as an opportunity for physicians, patient, industry and healthcare providers
Sven Stegemann (Speaker)
12 Nov 2017Activity: Talk or presentation › Invited talk › Science to science
-
UKPharmSci
Annalisa Mercuri (Speaker)
2 Sept 2013 → 4 Sept 2013Activity: Talk or presentation › Invited talk › Science to science
-
The very old and drug delivery - friend or foe
Sven Stegemann (Speaker)
29 Sept 2020Activity: Talk or presentation › Invited talk › Science to science
-
The pandemic – drawback or advance in patient centric drug development for older adults
Sven Stegemann (Speaker)
23 Oct 2020Activity: Talk or presentation › Invited talk › Science to science
-
The "Expectation to Treatment model" - An attempt to understand Patient behavior
Sven Stegemann (Speaker)
10 Sept 2016Activity: Talk or presentation › Invited talk › Science to science
-
The demographic & multimorbidity (r)evolution – an opportunity for pharmaceutical industry
Sven Stegemann (Speaker)
12 Sept 2019Activity: Talk or presentation › Invited talk › Science to science
-
Taking a fresh look to multiparticulates in the Age of Patient centric product design
Sven Stegemann (Speaker)
22 Sept 2016Activity: Talk or presentation › Invited talk › Science to science
-
Selecting and specifying capsule to achieve targeted fine particle release
Sven Stegemann (Speaker)
20 Sept 2018Activity: Talk or presentation › Invited talk › Science to science
-
Pharmaceutical Drug Product Design in the Context of Effectiveness and Safety and Their Importance in Achieving Therapeutic Outcomes
Sven Stegemann (Speaker)
24 Sept 2016Activity: Talk or presentation › Invited talk › Science to science
-
Patient Centric Medicine (PaCeMe) initiative: Building a “Road-Map” to patient centric product design
Sven Stegemann (Speaker)
16 Apr 2019Activity: Talk or presentation › Invited talk › Science to science
-
Opportunities for generic developers
Sven Stegemann (Speaker)
27 Jan 2016Activity: Talk or presentation › Invited talk › Science to science
-
Multimorbidität und hohes Alter – eine neue pharmazeutische und galenische Herausforderung
Sven Stegemann (Speaker)
23 Oct 2018Activity: Talk or presentation › Invited talk › Science to science
-
Meeting the Formulation and Delivery Needs of Special Patient Populations: Focus on Pediatrics and Geriatrics
Sven Stegemann (Speaker)
28 Oct 2021Activity: Talk or presentation › Invited talk › Science to science
-
Medicine development for the older and clinically complex patients – Closing the gaps to patient centric product design
Sven Stegemann (Speaker)
25 May 2018Activity: Talk or presentation › Invited talk › Science to science
-
ld and multimorbid – from patient involvement to better drug products
Sven Stegemann (Speaker)
2 Jun 2022Activity: Talk or presentation › Invited talk › Science to science
-
Investigating and selecting the optimal capsule based on capsule-formulation and device-capsule interaction to improve product performance.
Sven Stegemann (Speaker)
1 Mar 2016Activity: Talk or presentation › Invited talk › Science to science
-
Intensivtraining - Reinraumbekleidung/Der einzige Filter zwischen Mensch und Produkt
Stefan Liebminger (Speaker)
2 Dec 2010 → 3 Dec 2010Activity: Talk or presentation › Invited talk › Science to science
-
Intensivtraining - Reinraumbekleidung
Stefan Liebminger (Speaker)
23 May 2012 → 24 May 2012Activity: Talk or presentation › Invited talk › Science to science
-
In progress, Unique Identifiers on Dosage Forms to Prevent Counterfeits and Falsified Medicines
Sven Stegemann (Speaker)
11 Mar 2020Activity: Talk or presentation › Invited talk › Science to science
-
Hard gelatin capsule formulation development based on QbD
Sven Stegemann (Speaker)
27 Jan 2016Activity: Talk or presentation › Invited talk › Science to science
-
Hard capsules as a dosage form to close the gap between efficacy and effectiveness
Sven Stegemann (Speaker)
19 Jun 2017Activity: Talk or presentation › Invited talk › Science to science
-
From ‘me-too’ to ‘added value me too’ to ‘enhanced therapeutic’ (“supergeneric”): A way to create competitive advantages in the generic business
Sven Stegemann (Speaker)
22 Apr 2016Activity: Talk or presentation › Invited talk › Science to science
-
From patient research to patient centric product design: Focusing on the geriatric and pediatric population
Sven Stegemann (Speaker)
27 May 2016Activity: Talk or presentation › Invited talk › Science to science
-
Formulation for older people and synergies with pediatrics
Sven Stegemann (Speaker)
8 Apr 2016Activity: Talk or presentation › Invited talk › Science to science
-
Formulatión de medicamentos para uso pediatrico (Patient Centric solutions: The Sprinkle capsule in association with microparticulate formulations.)
Sven Stegemann (Speaker)
18 Feb 2016Activity: Talk or presentation › Invited talk › Science to science
-
Engineering particles to deliver high dosed and sensitive drugs to the lung using standard inhaler systems
Sven Stegemann (Speaker)
23 May 2019Activity: Talk or presentation › Invited talk › Science to science
-
Drug Research and Development for Adults Across the Older Age Span
Sven Stegemann (Speaker)
6 Aug 2020Activity: Talk or presentation › Invited talk › Science to science
-
Drug Research and Development for Adults Across the Older Age Span
Sven Stegemann (Speaker)
23 Oct 2020Activity: Talk or presentation › Invited talk › Science to science
-
Disruptive demographics – Longevity as a personal and societal opportunity
Sven Stegemann (Speaker)
9 Nov 2017Activity: Talk or presentation › Invited talk › Science to science
-
Considerations for interventions to increase effectiveness - Pharmacists view
Sven Stegemann (Speaker)
7 Sept 2016 → 10 Sept 2016Activity: Talk or presentation › Invited talk › Science to science
-
Closing the gaps in medicine development for the older population – Outcomes and actions from an APV workshop
Sven Stegemann (Speaker)
21 Mar 2018Activity: Talk or presentation › Invited talk › Science to science
-
Aus Patientensicht: Zwischen erleben, verstehen und einnehmen
Sven Stegemann (Speaker)
6 Mar 2016Activity: Talk or presentation › Invited talk › Science to science
-
Acceptability” – A marketing issue?
Sven Stegemann (Speaker)
22 Jun 2022Activity: Talk or presentation › Invited talk › Science to science
-
3rd Symposium in Quality by Design
Annalisa Mercuri (Speaker)
23 Mar 2015 → 24 Mar 2015Activity: Talk or presentation › Invited talk › Science to science
-
25 Years After the Ro5 – Trends in the Chemical Space and Drug Delivery
Sven Stegemann (Speaker)
27 Jun 2022 → 29 Jun 2022Activity: Talk or presentation › Invited talk › Science to science